It must not be enough to direct the new Broad Institute and be a professor at MIT: Eric Lander becomes a faculty member at Harvard Medical School in the systems biology department.
Invitrogen hires Karen Gibson, former VP of Global eBusiness and CIO for GE’s Medical Systems Information Technologies division, as its new CIO and senior vice president of information technology. Nicolas Barthelemy also joins Invitrogen as senior vice president of global operations after his last post at Biogen, where he was general manager and VP of manufacturing.
William Haseltine, a fixture on the genomics landscape, announces plans to retire later this year once another CEO is appointed to head up Human Genome Sciences, the company he founded in 1992.
Last seen as senior director for business development at Gene Logic, Anthony Recupero joins MaxCyte as vice president of biz dev to lead the company’s bioprocessing and drug discovery units.
This July, Michael Clegg will start as professor of biological sciences at the University of California, Irvine, where he will direct the Center in Evolutionary Genetics. Clegg is currently at UC-Riverside in botany.
After working in legal and corporate affairs at Exodus Communications, Gregory Liberman is now general counsel and corporate secretary at CytRx.
Jeffrey Williams resigns as president of Genomic Solutions to become CEO of another company. He’s replaced by David Strack, who was formerly vice president of sales and marketing at the company.
Michael Schubert is promoted to research and development VP at Bruker Daltonics. Before this, he was responsible for Bruker Daltonics'''' R&D activities in Bremen, Germany. Meanwhile, the company hires Seiichiro Tsurumaki as assistant vice president for Japan.
Eric Simone, a biomedical engineering undergraduate student at Johns Hopkins University, has built a microchip capable of manipulating individual DNA or protein molecules using a circular electrode design. Simone and the rest of the lab team are looking into detection and other applications for the chip.
Formerly CEO of TissueInformatics, recently acquired by Paradigm Genetics, Peter Johnson becomes executive vice president and chief medical officer of Paradigm. Mark Braughler, who was senior veep of business development at TissueInformatics, comes to Paradigm as VP of the same department.